1. This notice is issued in accordance with the letter from the Taiwan Food and Drug Administration, Ministry of Health and Welfare, dated November 3, 2026 (Ref. No. FDA-Controlled-1151800514), and the letter from the Ministry of Education dated November 11, 2026 (Ref. No. Tai-Jiao-Xue (5) 1150113429).

2. The so-called “smart drug” commonly available on the market, which contains the active ingredient Methylphenidate, is classified as a Schedule III controlled drug and is restricted to medical and scientific use. Any use outside these authorized purposes is considered illegal and may constitute a drug-related offense. Individuals who require this medication for medical reasons must first undergo a medical evaluation by a physician and obtain a valid prescription before it can be dispensed.

3. Please strengthen awareness campaigns targeting school faculty and staff, students, and parents. Remind everyone not to privately distribute, trade, or give away controlled drugs, as doing so may violate the law.

4. If any suspected illegal supply or other unlawful activities involving controlled drugs are discovered, please refer the matter to the appropriate law enforcement or investigative authorities for investigation and handling in accordance with relevant laws and regulations and their respective responsibilities.